Evercore ISI's Mark Mahaney likes Meta, but says other names will give more upside
Mark Mahaney, Evercore ISI head of internet research, joins 'Closing Bell' to discuss the markets, Meta's historic winning ...
Evercore ISI Remains a Buy on Ascendis Pharma (ASND)
In a report released yesterday, Gavin Clark-Gartner from Evercore ISI maintained a Buy rating on Ascendis Pharma (ASND – Research Report), with ...
Evercore ISI Reaffirms Their Buy Rating on Nisource (NI)
In a report released yesterday, Durgesh Chopra from Evercore ISI maintained a Buy rating on Nisource (NI – Research Report), with a price ...
Fintel on MSN12h
Evercore ISI Group Upgrades CRISPR Therapeutics (CRSP)
Fintel reports that on February 14, 2025, Evercore ISI Group upgraded their outlook for CRISPR Therapeutics (NasdaqGM:CRSP) ...
Evercore ISI Boosts The Carlyle Group (NASDAQ:CG) Price Target to $52.00
The Carlyle Group (NASDAQ:CG – Get Free Report) had its price target hoisted by analysts at Evercore ISI from $51.00 to $52.00 in a report issued on Wednesday,Benzinga reports. The firm presently has ...
Evercore ISI Issues Positive Forecast for Confluent (NASDAQ:CFLT) Stock Price
Confluent (NASDAQ:CFLT – Get Free Report) had its target price upped by Evercore ISI from $32.00 to $40.00 in a report ...